Last week, New Delhi-based Ranbaxy pleaded guilty in the United States to charges of making and distributing adulterated drugs made at its two Indian plants of Paonta Sahib and Dewas, agreeing to a $500 million settlement.
The lawsuit, filed in the U.S. district court in New York, alleged that, to promote Novartis drugs like Lotrel and Valturna, used for hypertension, and Starlix, for diabetes, the company paid doctors to make speeches at what were only "social...
'For employees who disclose compliance matters voluntarily, truthfully and fully ... and who cooperate unreservedly in investigating them, the executive board promises that it will not assert or enforce damage claims,' the company said.
Sanction relates to 2009 order for Microsoft to provide Web browser choice
Microsoft acknowledged failure to provide browser choice in Windows 7 introduction
EU has had a series of disputes with Microsoft
Judge said the jury erred in calculating damages for some of the devices in question, including some models of the Galaxy SII smartphone and Galaxy Tab tablet, and struck down as invalid the $450 million awarded to the Silicon Valley giant.